Overview
- 9 inspections across 8 sites are on record.
- 32 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2017-09-08.
At a glance
Inspections
9
Sites
8
Observations
32
Career since
Nov 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Laboratorios Grifols, S.A. | 8 Sep 2017 | Human Drugs | On file |
| B. Braun Melsungen Aktiengesellschaft | 29 Aug 2017 | Human Drugs | On file |
| Catalent Anagni SRL | 20 Nov 2015 | Human Drugs | View 483 → |
| Alfasigma SpA | 10 Nov 2015 | Human Drugs | View 483 → |
| ONESOURCE SPECIALTY PHARMA LIMITED | 8 Aug 2014 | Human Drugs | On file |
Sites inspected
Laboratorios Grifols, S.A.Parets Del Valles, Spain1 insp.
B. Braun Melsungen AktiengesellschaftMelsungen, Germany1 insp.
Catalent Anagni SRLAnagni, Italy1 insp.
Alfasigma SpAPomezia, Italy1 insp.
ONESOURCE SPECIALTY PHARMA LIMITEDBengaluru, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Kellia N Hicks2 shared
Chad N Thompson2 shared
Justin A Boyd2 shared
Michael R Goga1 shared
Natasha N Livingston1 shared
Ashley N Williams1 shared
Young M Yoon1 shared
Torrance J Slayton1 shared
Full investigator report
Get the verbatim findings behind Christophe T Peters' 32 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site